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Genetic information is increasingly provided outside of the traditional clinical setting,
allowing users to access it directly via specialized online platforms. This development is
possibly resulting in changing ethical and social challenges for users of predictive genetic
tests. Little is known about the attitudes and experiences of users of web-accessed
genetic information. This survey analyzes data from two European countries with regard to
the utility of genetic information, the users’ ways of making use of and dealing with
information, and their sharing behavior. Particular focus is given to ethical and social
questions regarding the motivation to share personal genetic results with others. Social
factors tested for are national background, gender, and marital, parental, and educational
status. This study will contribute to public discourse and offer ethical recommendations.
The study will also serve to validate the developed questionnaire for use in population
representative surveys.
Keywords: genomics, health information, attitudes, experiences, survey, lay people, utilityINTRODUCTION
Lay people are increasingly able to access digitized data regarding their personal health, ranging
from information provided by self-tracking and fitness apps to electronic patient records (Lupton,
2014; Rexhepi et al., 2018). Within this trend, genetic information has become widely available,
presenting lay people in the role of patients and consumers of health services with a variety of
implications and possibilities regarding application, utility and information sharing. Research has
shown that the public’s interest in genetic information is high (Townsend et al., 2012), and there are
different plausible reasons for that interest: Genetic tests can confirm or rule out genetic traits or a
suspected genetic condition, or they can help to determine a person’s chance of developing or
passing on a genetic disorder, and in some cases they provide relevant information that can be usedMarch 2020 | Volume 11 | Article 1021
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testing has “clinical utility”. Recently, scholars have discussed the
possibility that genetic testing also has “personal utility”, e.g., that
it plays a role in shaping individual understandings of disease or
personal identities of their carriers (Bunnik et al., 2015; Kohler
et al., 2017a; Kohler et al., 2017b; Urban and Schweda, 2018).
However, lay understandings of genetic information and its
implications diverge from those of experts, and may be shaped
by specific life situations, such as experience of disease, personal
attitudes and beliefs, and psycho-social circumstances (Oliveri
et al., 2015; Oliveri et al., 2016a; Oliveri and Pravettoni, 2018;
Oliveri et al., 2018), as well as by cultural background (Raz and
Schicktanz, 2016). Lay people’s perceptions are important
because they affect both their interest in undergoing genetic
testing as well as their interpretations of test results.
Some institutions offering genetic testing provide direct access
to own genetic test results via specialized online-platforms. This
article focuses on users of such direct access to personal genetic
information (i.e., lay people in regard to understanding genetic
information) and their specific attitudes and behaviors regarding
information sharing and the exercise of responsibility within
families (e.g., decisions regarding whether or not to inform
relatives about their genetic risks or regarding reproductive
behavior) (Welch and Burke, 1998; Anderson and Wasson,
2015; Baars et al., 2016). This perspective is relevant because
lay people often consider the decision to undergo genetic testing
to be an individual choice rather than a socially embedded
decision (Corpas, 2012; Schaper et al., 2018). Receiving genetic
risk information can potentially cause psychological harm
because some conditions are currently untreatable and being
affected may lead to stigmatization and discrimination
(Slaughter, 2006; Kollek and Lemke, 2008; Ross et al., 2015).
Furthermore, ethical conflicts may arise when the needs of the
client/patient do not accord with those of other family members
or society at large, and genetic counselors are increasingly faced
with conflicting obligations, e.g. when there is critical
information available that applies to multiple persons with
different information preferences (Muthuswamy, 2011). While
a moral duty may exist to share genetic information in order to
prevent harm to others, the nature of a specific condition and the
predicted harm associated with it need to be considered as well
(D’Agincourt-Canning, 2001; Parens and Appelbaum, 2019).
However, privacy and confidentiality are central issues in
genetic testing and making use of and dealing with genetic
information, and while there is consensus that individuals are
entitled to knowing about existing genetic information, a right
not to know has become the central moral norm, especially
regarding genetic risk of contracting a disease (Chadwick et al.,
2014; Domaradzki, 2015; Lupton and Michael, 2017).
A German study showed that lay people perceive risk
information as highly normatively charged, and often as an
emotionally significant threat (Wöhlke et al., 2019). It would
therefore seem to be necessary to provide lay people with a
deeper understanding of risk information and of the limitations
of genetic knowledgewith respect toone’s ownhealth responsibility
(Wöhlke and Perry, 2019). Similar results were found for lay peopleFrontiers in Genetics | www.frontiersin.org 2in Italy, who perceived genetic testing to be very helpful for disease
prevention but were simultaneously afraid that a positive result, the
detection of a genetic variant, could affect their life planning and
leave themwithout the ability to act to address the risk (Oliveri et al.,
2016a). Across Europe, the regulation of genetic testing is focused
on the prevention of harm to the individual—therefore, public
opinion should be taken into account in the creation of policy and
legislation regarding the communication of genetic risk (Oliveri
et al., 2016b).
Questions regarding the implications of personal access to
genetic information are becoming increasingly important in the
eHealth era, where health information is becomingmore accessible
to lay people in the role of patients and consumers as well as to
various other actors in the healthcare sector. Currently, there are
significant differences between countries in terms of the political
will to implement eHealth, available infrastructure, andactualuseof
these possibilities. Here, Germany and Italy offer contrasting
examples within Europe, with Germany being less advanced than
Italy in eHealth implementation efforts (Poss-Doering et al., 2018;
Thiel et al., 2019). Italian eHealth initiatives havemainly been in the
areas of improving access to health services and availability of
patients’ clinical histories, innovatingprimary care, and redesigning
the healthcare services network through Telemedicine
(Domenichiello, 2015). For this study, we conducted a survey of
Germans and Italians who have access to their personal genetic
information in order to gain a deeper insight into the practical and
ethical questions associated with accessing and sharing
such information.
Sharing of health information for more efficiency in health care
and research is a central notion in the eHealth paradigm. Privacy
and confidentiality are therefore important issues in relation to
personal data that are acknowledged by political decisionmakers in
both Germany and Italy (Thiel et al., 2019). The present notion of
sovereignty over one’s own genetic information touches a number
of ethical aspects related to both the self-determination and the
privacy of patients. However, it is unclear how the autonomy and
right to know of individuals can be reconciled with the self-
determination and right not to know of their family members.
The holder of genetic information has a special responsibility
because of its relevance for other biologically related persons
(Leefmann et al., 2017). With the introduction of the General
Data Protection Regulation (GDPR), a uniform legal requirement
for the handling of personal data was adopted in the European
Union, aimed at guaranteeing data security and data sovereignty.
However, there is great variety in how genetic testing is legally
definedandregulated internationally (Borry et al., 2012; Soini, 2012;
Varga et al., 2012). In both Germany and Italy, genetic testing for
medical purposes is subject to legislation that requires specialized
physicians and the provision of genetic counseling (Kalokairinou
et al., 2018).AIM
Given the topic outlined above, the overall aim of this study was
to gather information about the personal experiences and moralMarch 2020 | Volume 11 | Article 102
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use of and coping with genetic information and examine the
similarities and differences between German and Italian users
(lay people) of direct access to personal genetic information, and
the way these similarities and differences are related to age, sex,
and social and educational background.METHODS
In 2018, we conducted an online survey of persons with direct
access to their own genetic information, provided via centers for
human genetics in Germany and Italy.
The survey consisted of 13 questions in three thematic blocks
(see Supplementary 1):
a. Experience with genetic testing: questions concerning the
level of understanding of own genetic test results and
perceived controllability of their implications for health.
b. Personal opinion on genetic testing in general: questions
mainly concerning the utility of genetic testing, who should
undergo genetic testing, the right to know or not to know, and
regulation.
c. Making use of and dealing with test results: questions mainly
concerning preferences and reasons in sharing genetic own
genetic information.
Further, the survey included a set of sociodemographic
questions to contextualize the answers. The survey was initially
developed in German by the Göttingen research group. Its
content was developed based on the research question and
tailored to the target population based on previous experience
in studying lay perspectives on genetic testing with qualitative
methodology. The survey was adapted and improved in close
cooperation with the heads of GenomaLab and bio.logis
Zentrum für Humangenetik (ZfH) to meet the practicalities of
conducting the survey based on those institutions’ technical
infrastructure. Critical feedback from all co-authors was
included at an early stage of development. The survey was
successfully tested with academic staff of the German and
Italian research groups’ affiliation before application in the
study. The survey was translated into English by the Göttingen
research group, and thence from English to Italian for
application by the research groups in Italy. The Italian
translation was checked by translating it back into English.
In order to participate in the survey, participants had to read
and acknowledge the study information telling them that by
proceeding to the questionnaire and submitting it they gave
consent to participate.1A guest login to the genetic information services is available via https://my.
pgsbox.de, username: SurveyGER-I, password: GeneticInformation2019.
2https://www.laboratoriogenoma.eu – a guest login to the services is available via
https://www.genomagroup.com/LoginRefertazione.aspx?ln=EN, username:
SurveyITA-G, password: GeneticInformation2019a! (Access 25. September 2019).RECRUITMENT
We recruited participants who had undergone genetic testing
and had online access to their personal genetic information. In
the following sections we provide links to a sample account for
each website.Frontiers in Genetics | www.frontiersin.org 3German Sample
Participants were recruited via bio.logis (ZfH) in Frankfurt
(Main). bio.logis (ZfH) is a clinical institute for pre- and
postnatal genetic diagnostics and counselling which provides a
web-portal designed to give patients direct access to selected
categories of genetic information. Online access to genetic
information is offered only for selected categories, such as
pharmacogenetics, carrier status for recessively inherited
diseases, and preventive targets. Non-treatable conditions or
those whose diagnosis would lead to relatively invasive
treatments, such as pronounced surgical or chemotherapeutical
interventions, were excluded. Patients may log in to their
personal account and see the current status of genetic analyses
and results as well as news and updates provided by bio.logis
(ZfH).1 The User ID for access to the portal is provided directly
to patients and to their doctors, who in the majority of cases were
responsible for the referrals of patient’s samples. For the purpose
of recruitment users were contacted via an internal e-mail system
of the bio.logis (ZfH) portal. The survey data was then collected
online using the survey tool EvaSys. As an incentive, participants
were given the option to enter a raffle for four Amazon vouchers
of 50 Euros each. The recruitment mail started on May 9th, 2018.
A reminder was sent out on June 22nd, 2018 and the survey was
closed on August 31st.
Italian sample
Participants were recruited via GenomaLab - Molecular Genetics
Laboratory in Rome. GenomaLab (MGL) offers a variety of
genetic testing services, including screening tests for
predisposition to breast and colon cancer, cardiovascular
disease, and nutrigenetic and noninvasive prenatal testing.2
The survey was advertised on GenomaLab’s website, and
clients who had received their genetic results in the previous
two weeks were invited to participate. The link to the
questionnaire was sent to other clients two weeks after they
had received their genetic results. Data were collected using
Survey Monkey, an open source online survey application which
enables users to develop and publish surveys and register
responses (www.surveymonkey.com). Recruitment started in
April 2018 and ended in October 2018.STATISTICAL ANALYSIS
The analysis was performed using SPSS statistics (version 25).
Descriptive statistics were calculated on raw data to depict the
socio-demographic characteristics of both German and Italian
samples. Frequencies were performed on the total distribution of
our sample, whereas contingency tables and Chi-Square tests
were performed to make comparisons based on country of
origin, gender, age range, educational level, and parental statusMarch 2020 | Volume 11 | Article 102
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were calculated. Contingency tables allowed us to verify whether
a specific group (German vs. Italian participants) gave a
significantly higher or lower rate of response (observed values)
to certain items compared to the percentage expected and
calculated according to the number of subjects recruited
(expected values). The analysis focused on which groups
agreed to certain positions and the comparison of national,
gender and age differences.RESULTS
A sample of 192 participants was enrolled. The response rate for
Germany was 7% (n=103 of 1,517 persons contacted). Of the
1,860 Italian clients who underwent genetic testing in the period
of recruitment, n = 89 completed the questionnaire, a response
rate of 5%. The gender distribution reflected the overall
membership distribution here.
Overall, respondents were 28% men and 69% women, with
2% not defined, and 1% not responding. 52% had previous
experience with genetic testing (41% participants had no
experience). The sample comprised Christians (62%),
Agnostics (6%), and nonreligious people (27%). The socio-
demographic characteristics of the German and Italian samples
are described in Table 1.
Experience With Predictive Genetic
Testing
When asked about their experience with genetic testing and
genetic information, 89% of German participants and 87% of
Italian participants answered that they understood the reports on
their genetic data, while 6% of German participants and 10% of
Italian participants answered that they did not understand the
reports on their genetic data (Figure 1).
When asked if they were able to explain the results to others
(e.g., family members), 77% of German participants and 79% of
Italian participants answered affirmatively, while 12% of German
participants and 13% of Italian participants answered negatively
(Figure 1). No significant differences were found based on
sociodemographic variables, such as gender, parental status,
education, etc.
Apart from these similarities, there were significant
differences among German and Italian participants: more
Italian participants answered that they felt they could act in
some way against a genetic predisposition (73% versus 55% of
German participants), and more German participants answered
that they felt they could not act in any way (24% versus 11% of
Italians) (X2(1, N = 168) = 4.676, p < 0.01) (Figure 1).
Attitudes Toward Predictive Genetic
Testing
German participants answered more frequently that genetic
testing was useful to “understand myself” (60% vs. 21% of
Italian participants, with a significant difference, Χ2(1, N =
192) = 29.540, p < 0.01), and that genetic information hadFrontiers in Genetics | www.frontiersin.org 4entertainment value to them (15% compared to 0% of Italians,
Χ2(1, N = 192) = 14.060, p < 0.01). By contrast, Italian
participants answered more frequently that genetic results are
useful for other people, such as their family members (40% vs.
12% of German participants) (X2(1, N = 192 21.119, p < 0.01)
(Figure 2).
Interestingly, only 5% of women answered that genetic
information had entertainment value to them; compared to 15%
of the men, with a significant difference (X2 (1, N = 186) = 4.676,
p < 0.01).
55% of participants without children agreed that genetic
testing “is helping me to understand myself” compared to 35%
of participants with children, with a significant difference (X2(1,
N = 176) = 7.049, p < 0.01). In particular, German participants
without children were significantly more likely to state that
genetic information “is helping me to understand myself”
(79%) than Italian participants with (12%) and without (29%)
children (X2(3, N = 176) = 41.344, p < 0.01). A similar result
emerged for the question whether results have entertainment
value, with 23% of German participants without children opting
for this answer compared to 0% of Italian participants regardless
of their parental status (X2(1, N = 176) = 17.812, p < 0.01). Italian
participants with children considered genetic test results as
“important for others (e.g., family, kids)” more frequently
(54%) than German participants with (12%) and without
(10%) children (X2(1, N = 176) = 30.335, p < 0.01) (Figure 3).TABLE 1 | Sociodemographic data.
Variables Germany Italy
N % N %
Number of participants 103 53.6 89 46.4
Male 41 21.4 13 6.8
Female 60 31.2 72 37.5
Not defined 2 1.0 4 1.0
Age (years)
18–25 – – 5 2.6
26–35 23 12 28 14.6
36–50 25 13 33 17.2
51–70 49 25.5 19 10
70+ 4 2.1 – –
Missing 2 4
Marital status
Single 21 11 15 7.8
Married 68 35.4 42 21.9
Life-partnership 7 3.6 24 12.5
Widowed 6 3.1 2 1.0
Missing 1 6
Number of children
None 39 20.3 35 18.2
One 30 15.6 21 10.9
Two 17 8.9 17 8.9
Three or more 14 7.3 2 1.0
Missing 3 14
Level of education
Academic degree
Vocational school
High school
year 10year 9
No education
64
7
13
14
2
0
36.3
6.9
12.7
13.7
2.0
0
45
3
28
1
3
0
24.7
3.8
35
1.3
3.8
0
Missing 9March 2020 | Volume 11 | Article 102
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that everybody should undergo genetic testing for disease risk
prediction to get information about personal disease risks,
against 33% of participants who were against this option, and
20% who were unsure.
German participants responded more often that patients/
clients have a right not to know about disease predisposition
regardless of the circumstances (84%), compared to Italian
participants (38%), who answered more frequently that such a
right exists “in no case” and “do not know”, (X2(3, N = 187) =
53.186, p < 0.01). Women tended to answer more frequently that
patient/clients have a right not to know about disease
predisposition (16%) than men (0%), this difference was
significant (X2(3, N = 184) = 11.439, p < 0.01) (Figure 4).
Italian participants responding “in no case” were all women
and were mostly aged between 26–35 (33%) or 36–50 (33.3%).
They were predominantly married (57%) and had an academic
level of education (57%). 52% had children, whereas 38% did not.
76% already had previous experience with genetic testing. TheyFrontiers in Genetics | www.frontiersin.org 5wanted to share genetic results mainly with their partner (81%),
parents (67%), and children (57%), and they actually shared
results with the partner (81%) and parents (76%) at roughly the
same frequency as they wanted, but not with children (33%).
Interestingly, only 23% of this group of women answered that
the main reasons for sharing genetic results with family members
would be “the right to share”. Other responses included: 19%
“have trust in others”, 10% “share the burden”, 14% “receive
comfort”, 5% “feel responsible for their life”, and 38% “It is
important for reproductive planning”. Most answered “They
have a right to know” (47%).
German participants answered more often that for them
genetic information means certainty (59% vs. 30% Italians, (X2
(1, N = 192) = 16.047, p < 0.01), and claimed that genetic testing
includes preventive possibilities (93% vs. 83% Italians, Χ2(1, N =
192) = 4.761, p < 0.05). Significant differences were also evident
regarding the perceived possibility of life planning with a view to
one’s own professional life (43% German participants vs. 17%
Italian participants, Χ2(1, N = 192) = 15.005, p < 0.01), theFIGURE 1 | Experiences with predictive genetic testing.FIGURE 2 | Attitudes regarding utility towards predictive genetic testing.March 2020 | Volume 11 | Article 102
FIGURE 4 | Patients/Clients do have a right not to know about predisposition for a disease.
Wöhlke et al. Personal Utility and Personal Sharing Preferencespossibility of life planning with a view to family (63% German
participants vs. 43% Italian participants, Χ2(1, N = 192) = 7.998,
p < 0.01). German participants were also more likely to state that
genetic testing involves the risk of discrimination in health
insurance (32% German participants vs. 5% Italian
participants, Χ2(1, N = 192) = 23.284, p < 0.01) (Figure 5).
Women declared more often than men that genetic testing
for disease risk prediction means preventive possibilities (95%
of women vs. 80% of men) (X2(1, N = 186) = 9.953, p < 0.01).
More participants with a vocational school education (60%)
or academic degree (39%) answered that genetic testing
means a possibility of life planning with a view to one’s
professional life compared to the other groups, andFrontiers in Genetics | www.frontiersin.org 6particularly participants with high school education (15%)
(X2(4, N = 182) = 14,364, p < 0.01).
Specifically, German participants without children answered
“certainty” significantly more often (74%) compared to
Italian participants without (37%) and with children (24%)
(X2(3, N = 176) = 21.846, p < 0.01). German participants with
children more often stated that genetic testing allowed the
possibility of life planning with a view to profession (46%)
than Italian participants without children (9%) (X2(3, N =
176) = 16.680, p < 0.01). Italian participants without children
answered less frequently that genetic testing means the
possibility of life planning with a view to family compared to
the other groups (31% (X2(3, N = 176) = 12.573, p < 0.01).FIGURE 3 | Attitudes regarding utility towards predictive genetic testing selected in with and without children.March 2020 | Volume 11 | Article 102
FIGURE 5 | Attitudes towards opportunities and risks towards predictive genetic testing.
Wöhlke et al. Personal Utility and Personal Sharing PreferencesGerman participants without children were significantly more
likely to state that there is utility in the possibility of life planning
with a view to personal finances than Italians without children
(45% vs. 3%, Χ2(3, N = 176) = 13.316, p < 0.01). German
participants without (36%) and with children (30%) more
often saw a risk of discrimination in health insurance than
Italian participants with (2%) and without children (9%) (X2(3,
N = 176) = 20.005, p < 0.01) (Figure 6).
Italian participants stated more often (74%) than German
participants (47%) that predictive genetic testing is generally
useful, and significantly less often that predictive genetic testing
is useful in the case that an effective treatment is available (24%
compared to 38% of Germans, Χ2(3, N = 188) = 17.557, p < 0.05).
Italian participants without children answered significantly more
often that genetic testing is generally useful (80%) compared to
German participants with children (42%) (X2(4, N = 174) =
25.742, p < 0.01). German participants with children answered
more frequently that genetic testing is useful in case an effective
treatment is available (47%) compared to the other groups (X2(4,
N = 174) = 25.742, p < 0.01).
When asked about regulations needed to offer genetic testing,
German participants answered more frequently that genetic
testing needs a standardization of test methods and limits (i.e.
reliable and comparable test procedures with comparable
properties) (69% vs. 51% Italian participants, Χ2(1, N = 192) =
6.737), medical guidelines (85% vs. 62% Italians, Χ2(1, N =
192) = 14.037, p < 0.01), directives for data protection (72% vs.
35%, Χ2(1, N = 192) = 26.396, p < 0.01), and the possibility of
effective treatment (49% vs. 29% Italian participants, Χ2(1, N =
192) = 7.460, p < 0.01).
Men answered more frequently that a standardization of test
methods and limits (76% vs. 57% women, Χ2(1, N = 186) =
5.961) and directives for data protection are important (70% vs.Frontiers in Genetics | www.frontiersin.org 750% women, Χ2(1, N = 186) = 6.451, p < 0.01). A standardization
of test methods and limits was also important to participants
with an academic degree (74% vs. 29% compared to the other
groups. High school 42% vs. 59%; ten years of education 47% vs.
53%; < 9 years of education 40% vs. 60% Χ2(4, N = 182) = 17.132,
p < 0.01).
Dealing With Genetic Test Results
Italian participants preferred to involve parents more than
Germans (64% vs. 42% of Germans, Χ2(1, N = 192) = 9.511,
p < 0.01). Italian participants without children stated that they
would share their test results with their parents (71%) more than
German participants without children (54%) and people with
children (63% Italians and 34% Germans) in general (X2(3, N =
176) = 15.009, p < 0.01).
More women than men stated they would share results with
their parents (60% of the women vs. 37% of the men, Χ2(1, N =
186) = 8.010, p < 0.01). Participants with an academic degree
answered (97%) they would share results with the partner more
frequently than the other groups (high school diploma 83% yes;
10 years of education 67% yes, < 9 years of education 100% yes)
Χ2(4, N = 182) = 20.407, p < 0.01).
Married participants wanted to share results with the partner
(98%) more than any other group (X2(3, N = 178) = 24.694, p <
0.01). Significantly more participants in a life-partnership stated
the intention to share results with their parents (75%) than
married (44%) and single participants (64%), Χ2(3, N = 178) =
11.110, p < 0.01).
Italian participants shared results with parents more
frequently than German participants (65% Italian participants
vs. 27% German participants, Χ2(1, N = 192) = 27.857, p < 0.01)
(Figure 7). German and Italian participants shared results with
their children equally (34% German participants and 42% ItalianMarch 2020 | Volume 11 | Article 102
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parents more than men (55% of the women vs. 24% of the men,
Χ2(1, N = 186) = 15.035, p < 0.01). Overall, there was a relatively
high willingness to share results within the social circle (89%
with the partner, 52% with parents, 52% with their children, 16%
with friends, of the whole sample of participants) while most of
the participants reported reluctance to share results with
employers (1%) and other institutions like health insurance
(6%) (Figure 7).
Considering the whole sample, 80% of participants had
actually shared results with the partner, 45% with the parents,
22% with their children, 26% with friends, whereas only 3
participants each actually shared results with health insurance
or with the employer. Only 1 participant reported to have shared
information with authorities (unspecified).
Differences were evident regarding the reasons for sharing
genetic information: German participants chose the answer
option “my right to test means that I can share the
information” more often (54%) than Italian participants (36%)
(X2(1, N = 192) = 6.521, p < 0.05). Similarly, German
participants answered more often “I have trust in others” (44%
vs. 19% of Italian participants, Χ2(1, N = 192) = 13.202, p < 0.01),
and “I feel responsible for their [family members] life” (34% vs.
19% for Italians, Χ2(1, N = 192) = 5.353, p < 0.05).
German participants without children answered “…means
that I can share the information” (69%, Χ2(1,N = 176) = 11.851,
p < 0.01), and “I have trust in others” (51%, Χ2(1, N = 176) =
11.851) more frequently than Italian participants without
children, and both German and Italian participants
with children.
Italian participants wanted to share genetic results mainly
with their partner (81%), parents (67%) and children (57%), and
they actually shared results with the partner (81%), parentsFrontiers in Genetics | www.frontiersin.org 8(76%) but not with children the same frequency they
wanted (33.3%).
Interestingly, only 23% of Italian participants answered that
the main reasons for sharing genetic results with family members
would be “the right to share”, 19% “have trust in others”, 10%
“share the burden”, 14% “receive comfort”, 5% “feel responsible
for their life”, 38% “It is important for reproductive planning”.
Most answered “They have a right to know” (47%).
Men report more trust in others than women (50% men vs.
26% women, Χ2(1, N = 186) = 10.219, p < 0.01), and feel more
responsible for their family members’ lives (40% men vs. 22%
women, Χ2(1, N = 186) = 6.785, p < 0.01). Participants with an
academic degree answered more frequently “I have trust in
others”, particularly compared to participants with high school
level (39% academic degree vs. 10% high school, Χ2(4, N = 182) =
15.465, p < 0.01).
Men answered more frequently that “…persons or
institutions can control me with the information” (9% men vs.
0% women, Χ2 (1,N = 186) = 12.560, p < 0.01).DISCUSSION
Our results provide empirical insights to the notions of “personal
utility” and “data sharing”, which are often used as umbrella
terms in discussions of the usability of genomic information. The
results show a relatively high willingness among participants to
share information with their social circle but an overall strong
reluctance to share data with official institutions (employers,
health insurance) due to fear of genetic discrimination. Several
studies showed that, while there are limits in regard to people’s
willingness to share genetic information, there is a significant
interest in sharing it for research purposes (e.g., in health dataFIGURE 6 | Attitudes towards opportunities and risks towards predictive genetic testing selected in with and without children.March 2020 | Volume 11 | Article 102
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O'Daniel, 2011; Hafen et al., 2014; Aitken et al., 2016; Thorogood
et al., 2018). This can be interpreted as openness to the shared
exchange of genetic information when societal benefits are
expected. The perspective may be different when it comes to
sharing information with other people and institutions, such as
insurance companies or employers, that have an interest other
than research.
Our data also supports the idea of Wöhlke et al. (2019) that
using genetic information can lead to stronger beliefs in self-
efficacy. The fact that patients are willing to share their data
within social groups shows that social objectives play an
important role, e.g., the comparison of health data with other
patients, or the exchange of information on dealing with the
disease and its treatment.
The danger of stigmatization and discrimination based on
genetic information is often cited as ethically problematic
(DiMillio et al., 2015; German Ethics Council, 2018). However,
only the German participants saw a significant danger of
discrimination in health insurance, and our study showed
overall little indication of fear of such negative consequences.
Genetic knowledge is therefore less often perceived as a risk of
individualization of health risks and loss of social solidarity, as
feared by some experts (Lemke et al., 2010; Wöhlke et al., 2015).
Instead, there is an apparent optimism regarding the possibilities
of sharing genetic information to everyone’s benefit—a notion
that also drives the development of new genetic data sharing
cooperatives (see Prainsack, 2017).
It is also interesting that many participants were unsure
whether it was advisable for everyone to undergo a genetic test.
A clear cultural difference is evident between German
respondents, who support the right not to know and find
aspects of personal utility of genetic information very
important, and Italian respondents, who saw the value of
genetic information more in terms of one’s own and family
prevention, i.e. in its potential to aid in exercising genetic
responsibility (Leefmann et al., 2017). Comparing the two
countries, it becomes clear that responsibility for the family
was more important among the Italian respondents and thatFrontiers in Genetics | www.frontiersin.org 9moral values are strongly influenced by this. In our view, these
findings indicate a plurality of lay moralities regarding duties and
rights related to genetic testing. They are in line with previous
studies of affected people, which found national differences
regarding the moral duty to undergo genetic testing (Raz and
Schicktanz, 2009), or moral conflicts regarding whether or not
one should know, and tell, in the context of Huntington’s Disease
(Konrad, 2005). Our findings suggest that a possible moral
obligation to share genetic information does not necessarily
depend on specific conditions or predicted negative outcomes
(D'Agincourt-Canning, 2001). Rather, moral obligation is closely
related to family responsibility (Leefmann et al., 2017). As our
results show, the Italian respondents associated a significantly
higher level of family responsibility with genetic information. In
contrast, German users appeared to place much more
importance on individual interest and benefit.
The vast majority of our participants claimed that they
understood their genetic reports. However, there are
differences in the assessment of the benefits of such data:
German participants were much more skeptical than Italian
participants that they could counter-balance a genetic
predisposition with preventive measures. In line with other
empirical studies (Paton et al., 2012; Sommer et al., 2013;
Lupton and Michael, 2017), we found that German
participants use genetic information to learn more about
themselves. In contrast, the motivation of Italian respondents
in dealing with genetic information is more focused on the
benefit to others, such as the family. This could be connected
to the fact that in Germany there is a tendency to discuss
individual genetic testing and genetic carrier screening
separately (German Ethics Council, 2013). Similarly, it is
striking that 1 in 4 Italians disagreed that one has a right not
to know about predisposition to a disease—this right is rarely
contested by experts and also exists as a legal right in both
countries (German Genetic Diagnostics Act §9, (2009) Oviedo
Convention 1997, Ar. 10, co 2). This could also be explained by
cultural differences regarding the value of family and
responsibility for others, which appears to be more significant
in Italy than Germany (Rodotà, 2006). In Italy the right not toFIGURE 7 | Dealing with genetic test results.March 2020 | Volume 11 | Article 102
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Convention: “Everyone has the right to know all the information
collected on their own health. However, the will of the person not
to be informed must be respected”. Nevertheless, despite the
current regulatory framework, the very nature of genetic
information limits individual choice in this field, since various
private law regulations affecting the family, community or
society become relevant and must be adapted to the peculiar
characteristics of genetic information. Therefore, with regard to
genetic information, the “right for personal health” prevails
(Rodotà, 2006).
Our results suggest that practices of dealing with digital
health-related data vary depending on the different legal
frameworks in which they are embedded. Also relevant are the
respective social and cultural frameworks, which refer to
standards of handling health-related data as well as the
demands and acceptance of the relevant actors (Lupton, 2014).
Moreover, technological progress often challenges legal
frameworks with new implications. Since 2015, there is a “Law
for Secure Digital Communication and Applications in Health
Care” (“eHealth Law”) in Germany (German Federal digital Law,
2015). This law provides for the establishment of an electronic
patient record, in which patients can store the self-collected
health data and make it available to their attending physician
(Federal Ministry of Health, 2015).
In addition to technical and political aspects, the resulting
legal and ethical consequences must also be considered (Frizzo-
Barker et al., 2016). In our view, more comparative studies on
data ownership involving lay people are necessary in order to
better understand cultural differences such as attitudes towards
the “right not to know” in the handling of genetic digital data.
The question of benefit primarily addresses different forms of
individual interest or benefit provided by genetic information
that go beyond improved health outcomes, and our findings
indicate that the information is used for “potential” prevention
for the benefit of others (e.g., future generations, one’s own
children). Cultural differences are evident in the value given to
genetic information for preventing financial, family or
professional problems. Those aspects were much more
important to the German participants than to the Italian ones.
In addition, there seems to be a cultural difference regarding the
perception of genetic information as providing certainty, which
was supported by about three-quarters of German participants
but by far fewer Italian participants. In line with other studies,
this could be an indication that in Germany genetic information
is perceived to be very useful since it is a product of scientific
insights and progress (Urban and Schweda, 2018).
Finally, some interesting differences emerged in our sample
based on educational level and gender. It seems that people with
an academic education tend to consider genetic risk
information as something useful for the professional life
planning and that a standardization of methods and limits for
genetic analysis is paramount for them. Further, they are more
interested in sharing results with their partner and have trust in
other people when deciding to share their personal information
such as a genetic risk predisposition. Moreover, among theFrontiers in Genetics | www.frontiersin.org 10Italian population, people with an academic degree also
believed more in the notion that there is no “right not to
know”. Our results show that people with higher education
show greater openness to share this type of personal
information, especially if they are generated with reliable
methods, and in particular in the Italian context, excluding
the right not to know”. Other studies have been conducted in
the past on the attitudes toward genetic testing and their
perceived utility, that have revealed differences based on the
level of education, too (Haga et al., 2013; Roberts et al., 2017;
Flatau et al., 2018; Schaper and Schicktanz, 2018). Our study
also showed gender differences regarding the perceived utility
of genetic testing and attitudes towards data sharing, such as
the fact that women consider undergoing genetic testing as a
preventive possibility and they want to share (and actually
share) the results with parents more than men. Men on the
other hand have higher privacy concerns and appear to be more
interested in standardization of test methods and limits and
directives for data protection, since they are worried about the
possibility that persons or institutions can control them using
genetic risk information. While gender differences regarding
attitudes toward genetic testing have been observed in several
other studies in different countries, there seems to be no clear
recurring pattern this finding relates to, probably because of
different studied populations and varying study designs and
methods (Aro et al., 1997; Henneman et al., 2013).LIMITATIONS
This work is explorative in nature and subject to several
limitations in regard to representativeness. Given the narrow
field of research and the research question, the total target
population is very small. The difference in response rates
between the countries may be attributed to the use of
incentives in the German setting. However, in both countries
the response rate was very low, which might lead to sample bias.
We cannot generalize our findings to the broader population;
however, we may assume that it is somewhat representative of
the smaller target population. The invitation mail in the German
data collection technically allowed participants to share the link
or participate in the survey multiple times. In in an unknown
number of cases, doctors keep patients’ User IDs, making it
impossible for the latter to respond. A limitation of the survey
and related statistical analysis is the lack of continuous variables,
which did not allow analysis of variance in investigating
group differences.CONCLUSIONS
Our survey demonstrates the importance of cross-cultural
comparisons (Raz and Schicktanz, 2016) to better understand
national differences and similarities in lay perspectives in regard
to using und sharing genetic information to indicate
responsibilities and reservations. Our findings contribute to theMarch 2020 | Volume 11 | Article 102
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Above all, the broad spectrum of different attitudes shows that
lay people see a great potential for prevention, and that predictive
genetic tests will in future increase lay people’s perceived
responsibility for their own health.
This raises the question of how individual autonomy and the
right to know can be reconciled with the self-determination of
family members and their right not to know. Predictive genetic
tests can lead to an overestimation of the predictive ability of
genetic information. At the same time, neglecting social risk
factors for certain diseases could be both physically and
psychologically detrimental for those affected. As we become
increasingly exposed to genetic information in our lives, it is all
the more important that we, as citizens, patients or consumers,
are sensitized to, or “socialized” with, ethical questions arising
from such information (Parry and Middleton, 2017; Roberts
and Middleton, 2017). However, more information and
educational work is needed while genetic information is
combined with prevention measures aimed purely at medical
interventions or family planning. In the private, family or
professional spheres alike, there is a lack of information
about which preventive measures can be affected by genetic
knowledge. Communication challenges also arise beyond the
handling of predictive information. For example, it is important
not only to educate lay people about the opportunities and risks
of using their genetic information, but also to avoid raising
unrealistic expectations by, for example, making a factual
distinction between individual therapeutic and future benefits
for patients.OUTLOOK
The sharing of genetic information via digitized patient records
promises a more transparent, efficient and secure flow of
information between patients, physicians and other groups in
the healthcare system (Lupton, 2014). Therefore, in addition to
technical and political solutions, the resulting legal and ethical
consequences must also be considered (Frizzo-Barker et al.,
2016). In our view, more comprehensive studies on data
ownership involving lay people are necessary in order to do
justice to cultural differences such as the “right not to know” in
the digital age. Further, there seem to be interesting correlations
between sociodemographic factors and willingness to share
genetic information worth investigating. In order to evaluate
future ethical problems that may arise through the integration of
genetic information into eHealth and to guarantee informational
self-determination, the perspectives of lay people (as users)
should be taken into account along with those of experts
during the development of these new digital technologies
(Hartzler et al., 2013).
Since most users only partially comprehend the complex
mutual relationship between data generation and use and their
consequences, ethical aspects of dealing with digital health-
related data, e.g. with regard to data protection and data
autonomy, should be prioritized (Rothstein, 2015).Frontiers in Genetics | www.frontiersin.org 11DATA AVAILABILITY STATEMENT
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